Flipping the script on tobacco
The Ohio State University Tobacco Center of Regulatory Science is using the industry’s nicotine playbook to maximize public health
Learn more
Discovery & Innovation
Health Talks: National study to help inform regulation of tobacco products
Our expert explains a national tobacco study led by Ohio State that will help inform the FDA’s regulation of tobacco products to children and teens.
A new research grant funded by the Food and Drug Administration (FDA) and the National Cancer Institute will enable The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute to conduct a national tobacco study to provide evidence to the FDA to help inform the regulation of tobacco products, specifically e-cigarettes and tobacco pouches. The study is being led by Theodore Wagener, PhD, director of the Center for Tobacco Research, and Peter Shields, MD, medical oncologist.
Through the Tobacco Center of Regulatory Science (TCORS) grant, researchers will look at how nicotine products can be regulated and marketed to be less appealing and addictive to young people while still supporting smokers and smokeless tobacco users looking to switch to less harmful alternatives.
Watch the full Health Talks video above to learn more about:
- The difference between e-cigarettes and tobacco pouches
- How tobacco products are marketed to kids
- The goals and impact of the national tobacco study
- Ohio State’s TCORS grant
Topics
Related websites
Recent Videos
Articles on Discovery & Innovation
Cancer
Unraveling the genetics behind cancer
By sequencing a person’s genes, a physician-scientist at The James is developing targeted therapies for patients with advanced cancer.
Treatment Advances
Psilocybin trial offers hope for those with treatment-resistant depression
Psychedelics could offer hope to those who have long-term struggle with depression. Early studies show promise but require more research and face numerous challenges.